An animal model to study local oxidation of LDL and its biological effects in the arterial wall

被引:69
作者
Calara, F [1 ]
Dimayuga, P
Niemann, A
Thyberg, J
Diczfalusy, U
Witztum, JL
Palinski, W
Shah, PK
Cercek, B
Nilsson, J
Regnström, J
机构
[1] Karolinska Hosp, King Gustaf V Res Inst, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden
[3] Huddinge Univ Hosp, Dept Med Lab Sci & Technol, Div Clin Chem, S-14186 Huddinge, Sweden
[4] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA
[5] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[6] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
关键词
atherosclerosis; oxLDL; nuclear factor-kappa B; intercellular adhesion molecule-1;
D O I
10.1161/01.ATV.18.6.884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidized LDL (oxLDL) is present in atherosclerotic lesions and is believed to play a key role in atherogenesis. Mainly on the basis of cell culture studies, oxLDL has been shown to produce many biological effects that influence the atherosclerotic process. To study LDL oxidation in vivo, we have established a model in which Sprague-Dawley rats are given a single injection of unmodified human LDL (greater than or equal to 4 mg/kg body weight). Within 6 hours, an accumulation of apolipoprotein B and epitopes present on oxLDL are detected in the arterial endothelium and media. The presence of oxLDL is associated with activation of the transcription factor nuclear factor-kappa B in the endothelium as well as endothelial expression of intercellular adhesion molecule-1. Injection of LDL enriched with the antioxidant probucol resulted in arterial accumulation of apolipoprotein B, but the expression of oxLDL-specific epitopes was reduced at 24 hours. Thus, this simple model has the potential to analyze the mechanisms behind and biological effects of LDL oxidation in vivo.
引用
收藏
页码:884 / 893
页数:10
相关论文
共 66 条
[11]   LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-1 (LFA-1) INTERACTION WITH INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IS ONE OF AT LEAST 3 MECHANISMS FOR LYMPHOCYTE ADHESION TO CULTURED ENDOTHELIAL-CELLS [J].
DUSTIN, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1988, 107 (01) :321-331
[12]  
ELSAADANI M, 1989, J LIPID RES, V30, P627
[13]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[14]   PLASMA-MEMBRANE CAVEOLAE MEDIATE THE EFFLUX OF CELLULAR FREE-CHOLESTEROL [J].
FIELDING, PE ;
FIELDING, CJ .
BIOCHEMISTRY, 1995, 34 (44) :14288-14292
[15]   ANTIOXIDANT DEFENSES AND LIPID-PEROXIDATION IN HUMAN-BLOOD PLASMA [J].
FREI, B ;
STOCKER, R ;
AMES, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9748-9752
[16]   OXIDIZED LOW-DENSITY LIPOPROTEIN INDUCES DIFFERENTIATION AND ADHESION OF HUMAN MONOCYTES AND THE MONOCYTIC CELL-LINE U937 [J].
FROSTEGARD, J ;
NILSSON, J ;
HAEGERSTRAND, A ;
HAMSTEN, A ;
WIGZELL, H ;
GIDLUND, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :904-908
[17]   BIOLOGICALLY MODIFIED LDL INCREASES THE ADHESIVE PROPERTIES OF ENDOTHELIAL-CELLS [J].
FROSTEGARD, J ;
HAEGERSTRAND, A ;
GIDLUND, M ;
NILSSON, J .
ATHEROSCLEROSIS, 1991, 90 (2-3) :119-126
[18]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[19]   ENHANCED MACROPHAGE DEGRADATION OF BIOLOGICALLY MODIFIED LOW-DENSITY LIPOPROTEIN [J].
HENRIKSEN, T ;
MAHONEY, EM ;
STEINBERG, D .
ARTERIOSCLEROSIS, 1983, 3 (02) :149-159
[20]   APOLIPOPROTEIN-B RETENTION IN GROSSLY NORMAL AND ATHEROSCLEROTIC HUMAN AORTA [J].
HOFF, HF ;
HEIDEMAN, CL ;
GOTTO, AM ;
GAUBATZ, JW .
CIRCULATION RESEARCH, 1977, 41 (05) :684-690